Mitoxantrone Unknown Status Phase 2 Trials for Myelodysplastic Syndromes / Drug/Agent Toxicity by Tissue/Organ / Neutropenia / Leukemias Supportive Care

IndicationsStatusPurposePhase
Unknown StatusSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003407Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia